BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 20544224)

  • 21. Valacyclovir for the prevention of recurrent herpes simplex virus eye disease after excimer laser photokeratectomy.
    Asbell PA
    Trans Am Ophthalmol Soc; 2000; 98():285-303. PubMed ID: 11190029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term follow-up of HIV-infected patients once diagnosed with acyclovir-resistant herpes simplex virus infection.
    Seang S; Boutolleau D; Burrel S; Regnier S; Epelboin L; Voujon D; Valantin MA; Katlama C; Agut H; Caumes E
    Int J STD AIDS; 2014 Aug; 25(9):676-82. PubMed ID: 24535691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Penciclovir cream--improved topical treatment for herpes simplex infections.
    Schmid-Wendtner MH; Korting HC
    Skin Pharmacol Physiol; 2004; 17(5):214-8. PubMed ID: 15452407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural history of neonatal herpes simplex virus infections in the acyclovir era.
    Kimberlin DW; Lin CY; Jacobs RF; Powell DA; Frenkel LM; Gruber WC; Rathore M; Bradley JS; Diaz PS; Kumar M; Arvin AM; Gutierrez K; Shelton M; Weiner LB; Sleasman JW; de Sierra TM; Soong SJ; Kiell J; Lakeman FD; Whitley RJ;
    Pediatrics; 2001 Aug; 108(2):223-9. PubMed ID: 11483781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacology of new antiherpes agents: famciclovir and valacyclovir.
    Stein GE
    J Am Pharm Assoc (Wash); 1997; NS37(2):157-63. PubMed ID: 9069689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract.
    Gupta R; Wald A; Krantz E; Selke S; Warren T; Vargas-Cortes M; Miller G; Corey L
    J Infect Dis; 2004 Oct; 190(8):1374-81. PubMed ID: 15378428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [New developments and prospects of antiviral chemotherapy].
    Vogt M; Bernasconi E; Lüthy R
    Internist (Berl); 1992 Sep; 33(9):597-601. PubMed ID: 1328109
    [No Abstract]   [Full Text] [Related]  

  • 28. Antiviral agents for treatment of herpes simplex virus infection in neonates.
    Jones CA; Walker KS; Badawi N
    Cochrane Database Syst Rev; 2009 Jul; 2009(3):CD004206. PubMed ID: 19588350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections.
    Kimberlin DW; Lin CY; Jacobs RF; Powell DA; Corey L; Gruber WC; Rathore M; Bradley JS; Diaz PS; Kumar M; Arvin AM; Gutierrez K; Shelton M; Weiner LB; Sleasman JW; de Sierra TM; Weller S; Soong SJ; Kiell J; Lakeman FD; Whitley RJ;
    Pediatrics; 2001 Aug; 108(2):230-8. PubMed ID: 11483782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparing Treatment of Acute Retinal Necrosis With Either Oral Valacyclovir or Intravenous Acyclovir.
    Baltinas J; Lightman S; Tomkins-Netzer O
    Am J Ophthalmol; 2018 Apr; 188():173-180. PubMed ID: 29447915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nosocomial herpes simplex virus infection associated with oral endotracheal intubation.
    Hanley PJ; Conaway MM; Halstead DC; Rhodes LV; Reed J
    Am J Infect Control; 1993 Dec; 21(6):310-6. PubMed ID: 8122803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of oral lesions in HIV-positive patients.
    Baccaglini L; Atkinson JC; Patton LL; Glick M; Ficarra G; Peterson DE
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103 Suppl():S50.e1-23. PubMed ID: 17379155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The comparative effects of famciclovir and valacyclovir on herpes simplex virus type 1 infection, latency, and reactivation in mice.
    LeBlanc RA; Pesnicak L; Godleski M; Straus SE
    J Infect Dis; 1999 Sep; 180(3):594-9. PubMed ID: 10438344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in Leukemia.
    Styczynski J; Reusser P; Einsele H; de la Camara R; Cordonnier C; Ward KN; Ljungman P; Engelhard D;
    Bone Marrow Transplant; 2009 May; 43(10):757-70. PubMed ID: 19043458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Challenges of aciclovir-resistant HSV infection in allogeneic bone marrow transplant recipients.
    Anton-Vazquez V; Mehra V; Mbisa JL; Bradshaw D; Basu TN; Daly ML; Mufti GJ; Pagliuca A; Potter V; Zuckerman M
    J Clin Virol; 2020 Jul; 128():104421. PubMed ID: 32417677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Valacyclovir prophylaxis for herpes simplex virus infection or infection recurrence following laser skin resurfacing.
    Beeson WH; Rachel JD
    Dermatol Surg; 2002 Apr; 28(4):331-6. PubMed ID: 11966791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of the Emergence of Acyclovir-Resistant Herpes Simplex Virus Type 1 With Prognosis in Hematopoietic Stem Cell Transplantation Patients.
    Kakiuchi S; Tsuji M; Nishimura H; Yoshikawa T; Wang L; Takayama-Ito M; Kinoshita H; Lim CK; Fujii H; Yamada S; Harada S; Oka A; Mizuguchi M; Taniguchi S; Saijo M
    J Infect Dis; 2017 Mar; 215(6):865-873. PubMed ID: 28453848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Herpes Virus, Oral Clinical Signs and QoL: Systematic Review of Recent Data.
    Crimi S; Fiorillo L; Bianchi A; D'Amico C; Amoroso G; Gorassini F; Mastroieni R; Marino S; Scoglio C; Catalano F; Campagna P; Bocchieri S; De Stefano R; Fiorillo MT; Cicciù M
    Viruses; 2019 May; 11(5):. PubMed ID: 31117264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. During the Emergency Department Evaluation of a Well-Appearing Neonate with Fever, Should Empiric Acyclovir Be Initiated?
    Bruno E; Pillus D; Cheng D; Vilke G; Pokrajac N
    J Emerg Med; 2018 Feb; 54(2):261-265. PubMed ID: 29198381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emerging therapies for herpes viral infections (types 1 - 8).
    Chakrabarty A; Pang KR; Wu JJ; Narvaez J; Rauser M; Huang DB; Beutner KR; Tyring SK
    Expert Opin Emerg Drugs; 2004 Nov; 9(2):237-56. PubMed ID: 15571482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.